Search Results

  • Showing 1 - 10 results of 10
Refine Results
  1. 1

    Long-term outcomes of a randomized, open-label, phase II study comparing cabazitaxel versus paclitaxel as neoadjuvant treatment in patients with triple-negative or luminal B/HER2-n... by Meyer-Wilmes, Philipp (Author) , Huober, Jens (Author) , Untch, Michael (Author) , Blohmer, J. -U. (Author) , Janni, W. (Author) , Denkert, Carsten (Author) , Klare, P. (Author) , Link, T. (Author) , Rhiem, K. (Author) , Bayer, C. (Author) , Reinisch, M. (Author) , Bjelic-Radisic, V. (Author) , Zahm, Dirk-Michael (Author) , Hanusch, Claus Alexander (Author) , Solbach, C. (Author) , Heinrich, G. (Author) , Hartkopf, A. D. (Author) , Schneeweiss, Andreas (Author) , Fasching, Peter Andreas (Author) , Filmann, N. (Author) , Nekljudova, V. (Author) , Holtschmidt, J. (Author) , Stickeler, E. (Author) , Loibl, Sibylle (Author) ,


    Get full text
    Article (Journal) Online Resource
  2. 2

    Myofibroblastic CAF density, not activated stroma index, indicates prognosis after neoadjuvant therapy of pancreatic carcinoma by Heger, Ulrike (Author) , Martens, Anna (Author) , Schillings, Lisa (Author) , Walter, Britta (Author) , Hartmann, Domenic (Author) , Hinz, Ulf (Author) , Pausch, Thomas (Author) , Giese, Nathalia (Author) , Michalski, Christoph (Author) , Hackert, Thilo (Author) ,


    Get full text
    Article (Journal) Online Resource
  3. 3

    Treatment of angiosarcoma with pazopanib and paclitaxel: results of the EVA (Evaluation of Votrient® in Angiosarcoma) phase II trial of the German Interdisciplinary Sarcoma Group (... by Pink, Daniel (Author) , Andreou, Dimosthenis (Author) , Bauer, Sebastian (Author) , Brodowicz, Thomas (Author) , Kasper, Bernd (Author) , Reichardt, Peter (Author) , Richter, Stephan (Author) , Lindner, Lars (Author) , Szkandera, Joanna (Author) , Grünwald, Viktor (Author) , Kebenko, Maxim (Author) , Kirchner, Marietta (Author) , Hohenberger, Peter (Author) ,


    Get full text
    Article (Journal) Online Resource
  4. 4

    Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally adv... by Miles, David W. (Author) , Gligorov, J. (Author) , André, F. (Author) , Cameron, D. (Author) , Schneeweiss, Andreas (Author) , Barrios, C. (Author) , Xu, B. (Author) , Wardley, A. (Author) , Kaen, D. (Author) , Andrade, L. (Author) , Semiglazov, V. (Author) , Reinisch, M. (Author) , Patel, S. (Author) , Patre, M. (Author) , Morales, L. (Author) , Patel, S. L. (Author) , Kaul, M. (Author) , Barata, T. (Author) , O’Shaughnessy, J. (Author) , Zhang, Q. (Author) , Shao, Z. (Author) , Wang, X. (Author) , Geng, C. (Author) , Yan, X. (Author) , Tong, Z. (Author) , Shen, K. (Author) , Yin, Y. (Author) , Sun, T. (Author) , Yang, J. (Author) , Feng, J. (Author) , Yan, M. (Author) , Wang, Y. (Author) , Liu, Q. (Author) , Zhang, S. (Author) , De Laurentiis, M. (Author) , Santoro, A. (Author) , Guarneri, V. (Author) , Colleoni, M. (Author) , Natoli, C. (Author) , Cortesi, L. (Author) , Placido, S. (Author) , Gianni, L. (Author) , Ferrau, F. (Author) , Livi, L. (Author) , Zambelli, A. (Author) , Del Mastro, L. (Author) , Tonini, G. (Author) , Montemurro, F. (Author) , Bianchi, G. (Author) , Pedersini, R. (Author) , Prete, S. (Author) , Allegrini, G. (Author) , Naso, G. (Author) , Vici, P. (Author) , Loirat, D. (Author) , Mailliez, A. (Author) , Priou, F. (Author) , Tredan, O. (Author) , Dalenc, F. (Author) , Perrin, C. (Author) , Timar David, M. (Author) , Dohollou, N. (Author) , Teixeira, L. (Author) , Brocard, F. (Author) , Arnaud, A. (Author) , Delaloge, S. (Author) , Spano, J. -P. (Author) , Mansi, L. (Author) , Damian, F. (Author) , Pedrini, J. (Author) , Aleixo, S. (Author) , Hegg, R. (Author) , Junior, R. (Author) , Schmidt, M. (Author) , Wenzel, C. (Author) , Grischke, E. -M. (Author) , Schneeweiss, A. (Author) , Just, M. (Author) , Harbeck, N. (Author) , Schumacher, C. (Author) , Peters, U. (Author) , Fischer, D. (Author) , Forstbauer, H. (Author) , Liersch, R. (Author) , Warner, E. (Author) , Bouganim, N. (Author) , Doyle, C. (Author) , Price Hiller, J. (Author) , Vandenberg, T. (Author) , Pavic, M. (Author) , Robinson, A. (Author) , Roldan Urgoiti, G. (Author) , Califaretti, N. (Author) , Alacacioglu, A. (Author) , Gumus, M. (Author) , Yalcin, B. (Author) , Cicin, I. (Author) , Kose, F. (Author) , Uygun, K. (Author) , Kaplan, M. (Author) , Cubukcu, E. (Author) , Harries, M. (Author) , Miles, D. (Author) , Doval, D. (Author) , Gupta, S. (Author) , Mohapatra, P. (Author) , Chatterjee, S. (Author) , Ghadyalpatil, N. (Author) , Singhal, M. (Author) , Nag, S. (Author) , Agarwal, A. (Author) , Wolf, I. (Author) , Gal Yam, E. (Author) , Yerushalmi, R. (Author) , Peretz, T. (Author) , Fried, G. (Author) , Ben Baruch, N. (Author) , Katz, D. (Author) , Hamilton, E. (Author) , Kayali, F. (Author) , Brufsky, A. (Author) , Telli, M. (Author) , Wright, G. (Author) , Oyola, R. (Author) , Rakowski, T. (Author) , Graff, S. (Author) , Tjulandin, S. (Author) , Aparicio, A. (Author) , Ruiz Borrego, M. (Author) , Merino, L. (Author) , Guerra Martinez, J. (Author) , Lopez, E. (Author) , Yamashita, T. (Author) , Ohtani, S. (Author) , Inoue, K. (Author) , Ito, Y. (Author) , Niikura, N. (Author) , Nakayama, T. (Author) , Sagara, Y. (Author) , Yanagita, Y. (Author) , Kamada, Y. (Author) , Kaneko, K. (Author) , Nervo, A. (Author) , Eniu, A. (Author) , Schenker, M. (Author) , Priester, P. (Author) , Melichar, B. (Author) , Zimovjanova, M. (Author) , Sormova, P. (Author) , Sufliarsky, J. (Author) , Kakalejcik, M. (Author) , Belbaraka, R. (Author) , Errihani, H. (Author) , Le Than, D. (Author) , Pham, D. (Author) , Aravantinos, G. (Author) , Papadimitriou, C. (Author) , Koumakis, G. (Author) , Papandreou, C. (Author) , Podolski, P. (Author) , Tabane, K. (Author) ,


    Get full text
    Article (Journal) Online Resource
  5. 5

    Final results from the PERUSE study of first-line pertuzumab plus trastuzumab plus a taxane for HER2-positive locally recurrent or metastatic breast cancer, with a multivariable ap... by Miles, David W. (Author) , Ciruelos, E. (Author) , Schneeweiss, Andreas (Author) , Puglisi, F. (Author) , Peretz-Yablonski, T. (Author) , Campone, M. (Author) , Bondarenko, I. (Author) , Nowecki, Z. (Author) , Errihani, H. (Author) , Paluch-Shimon, S. (Author) , Wardley, A. (Author) , Merot, J. -L. (Author) , Trask, P. (Author) ,


    Get full text
    Article (Journal) Online Resource
  6. 6

    The interference of selected cytotoxic alkaloids with the cytoskeleton: an insight into their modes of action by Wang, Xiaojuan (Author) , Tanaka, Mine (Author) , Krstin, Sonja (Author) , Peixoto, Herbenya (Author) , Wink, Michael (Author) ,


    Get full text
    Article (Journal) Online Resource
  7. 7

    Ramucirumab as second-line treatment for patients with metastatic esophagogastric adenocarcinoma by Hofheinz, Ralf-Dieter (Author) , Lorenzen, Sylvie (Author) ,


    Get full text
    Article (Journal) Online Resource
  8. 8

    Antiproliferative efficacies but minor drug transporter inducing effects of paclitaxel, cisplatin, or 5-fluorouracil in a murine xenograft model for head and neck squamous cell car... by Theile, Dirk (Author) , Gál, Zoltán (Author) , Warta, Rolf (Author) , Rigalli, Juan Pablo (Author) , Lahrmann, Bernd (Author) , Grabe, Niels (Author) , Herold-Mende, Christel (Author) , Dyckhoff, Gerhard (Author) , Weiß, Johanna (Author) ,


    Get full text
    Article (Journal) Online Resource
  9. 9

    Application of paclitaxel in low non-cytotoxic doses supports vaccination with melanoma antigens in normal mice by Sevko, Alexandra (Author) , Kremer, Veronika (Author) , Umansky, Ludmila (Author) , Umansky, Viktor (Author) ,


    Get full text
    Article (Journal) Online Resource
  10. 10

    Natural products derived from traditional chinese medicine as novel inhibitors of the epidermal growth factor receptor by Sertel, Serkan (Author) , Plinkert, Peter K. (Author) , Efferth, Thomas (Author) ,


    Get full text
    Article (Journal) Online Resource